1 Min Read
Feb 22 (Reuters) - Amgen Inc:
* ABARCA SAYS SIGNED OUTCOMES-BASED CONTRACT WITH AMGEN FOR CHOLESTEROL-LOWERING DRUG, REPATHA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.